Popular search terms:
Search Results
118 results found-
Our Products | CSL Behring Australia
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products -
Riastap Data Sheet
Resulting from these studies, as well as from long lasting clinical experience with fibrinogen products, dosage recommendations in the treatment of children are the same as for adults.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/riastap-nz-ds-v900-with-wfi.pdf -
Products List
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products/products-list -
Australian PI . tradename (active ingredient)
Resulting from these studies, as well as from long lasting clinical experience with fibrinogen products, dosage recommendations in the treatment of children are the same as for adults.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/riastap-au-pi-v900.pdf -
Product Orders
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
https://www.cslbehring.com.au/product-orders -
Riastap Data Sheet
Resulting from these studies, as well as from long lasting clinical experience with fibrinogen products, dosage recommendations in the treatment of children are the same as for adults.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/riastap-nz-ds-800b.pdf -
NEW ZEALAND DATA SHEET 1 PRODUCT NAME Prothrombinex®-VF powder and diluent for solution for injection 2 QUALITATIVE AND QUANTITA...
The risk that such products will transmit an infectious agent has been reduced by screening plasma donors for prior exposure to certain infectious agents and by testing for the presence of certain viral markers.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/prothrombinexvf-nz-ds-2000.pdf -
Healthcare Portal | CSL Behring Australia
CSL Behring Australia's Healthcare Portal
https://www.cslbehring.com.au/healthcare-portal -
Graduate Streams
CSL Behring's Graduate Program Home Page
https://www.cslbehring.com.au/careers/graduate-program/graduate-streams -
Australian PI . Biostate (FVIII / VWF)
In general, all patients treated with coagulation FVIII products should be carefully monitored for the development of inhibitors by appropriate clinical observations and laboratory tests.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/biostate-au-pi-v2600.pdf